Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based …
Over the last 12 months, insiders at Imunon, Inc. have bought $50,250 and sold $0 worth of Imunon, Inc. stock.
On average, over the past 5 years, insiders at Imunon, Inc. have bought $30,363 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lindborg Stacy (President and CEO) — $49,000. Tardugno Michael H (Executive Chairman of Board) — $25,750.
The last purchase of 25,000 shares for transaction amount of $25,750 was made by Tardugno Michael H (Executive Chairman of Board) on 2024‑08‑15.
2024-08-15 | Executive Chairman of Board | 25,000 0.2106% | $1.03 | $25,750 | -1.10% | |||
2024-08-15 | President and CEO | 25,000 0.2004% | $0.98 | $24,500 | -1.10% | |||
2022-04-12 | Chairman, President and CEO | 4,000 0.1156% | $3.53 | $14,129 | -53.88% | |||
2022-04-08 | 5,000 0.1657% | $4.05 | $20,250 | -58.42% | ||||
2022-03-02 | 2,000 0.0767% | $4.69 | $9,372 | -58.95% | ||||
2021-10-07 | director | 20,000 0.144% | $0.88 | $17,600 | -68.41% | |||
2021-05-17 | director | 5,000 0.0438% | $1.07 | $5,350 | -24.55% | |||
2020-02-28 | director | 5,000 0.0368% | $0.90 | $4,500 | 0.00% | |||
2019-11-20 | director | 6,000 0.0697% | $1.42 | $8,520 | -11.28% | |||
2019-11-06 | director | 10,000 0.1135% | $1.39 | $13,876 | -13.99% | |||
2019-11-04 | director | 4,000 0.0527% | $1.61 | $6,440 | -24.54% | |||
2019-08-02 | director | 10,000 0.1415% | $1.73 | $17,300 | -9.77% | |||
2019-07-25 | director | 6,000 0.0864% | $1.76 | $10,560 | -10.61% | |||
2019-07-24 | director | 10,000 0.1415% | $1.73 | $17,300 | -9.60% | |||
2019-06-19 | CFO | 5,000 0.0773% | $1.89 | $9,450 | -10.44% | |||
2019-05-16 | Chairman, President and CEO | 5,000 0.0884% | $2.16 | $10,810 | -23.72% | |||
2019-05-16 | director | 4,000 0.0704% | $2.15 | $8,600 | -23.72% | |||
2019-03-06 | director | 6,700 0.1167% | $2.13 | $14,267 | -17.14% | |||
2018-10-29 | Chairman, President and CEO | 7,500 0.1267% | $2.06 | $15,484 | -5.88% | |||
2018-10-03 | director | 4,900 0.1082% | $2.70 | $13,230 | -28.67% |
Tardugno Michael H | Executive Chairman of Board | 353346 2.4368% | $0.82 | 31 | 0 | <0.0001% |
Lindborg Stacy | President and CEO | 264166 1.8217% | $0.82 | 1 | 0 | |
LINK MAX | director | 380385 2.6232% | $0.82 | 12 | 0 | |
Martinez Alberto R Jr | director | 45000 0.3103% | $0.82 | 26 | 0 | <0.0001% |
PACE GARY W | director | 43356 0.299% | $0.82 | 3 | 0 |